Trachoma is the leading cause of infectious blindness in the world, with Ethiopia the most impacted country in Africa. In a clinical trial of more than 2,400 individuals, researchers led by Dr. John Kempen of Mass Eye and Ear found a topical anti-inflammatory treatment, fluorometholone, was not effective at reducing postoperative trachomatous trichiasis. Their research is published in The Lancet Global Health.
Source link
Clinical trial in Ethiopia targets the trachoma scourge
January 13, 2026
0 Comments
Explore More
Early surgery for bacterial eye infection offers hope to patients
Early vitrectomy surgery for acute endophthalmitis, a rare eye condition, may potentially benefit patients’ vision more than the current antibiotic-first approach, according to a study led by researchers at University
Virtual screening identifies potential treatments for inherited eye disease that causes blindness
Treatment with bioavailable small-molecule pharmacochaperones targeting the visual receptor rhodopsin offers a promising approach to prevent retinal photoreceptor degeneration caused by inherited mutations in this receptor. Credit: Beata Jastrzebska, created
Blinking less may mean brain is working harder, study shows
Blinking is a human reflex most often performed without thinking, like breathing. Although research on blinking is usually related to vision, a new Concordia study examines how blinking is connected